Additional Information
Book Details
Abstract
Trusted by generations of residents and practitioners, The Harriet Lane Handbook remains your first choice for fast, accurate information on pediatric diagnosis and treatment. The first medical reference book written "by residents, for residents" and reviewed by expert faculty at The Johns Hopkins Hospital, it continues to provide the gold standard in point-of-care clinical information for any health care professional treating pediatric patients.
- Consult this title on your favorite e-reader , conduct rapid searches, and adjust font sizes for optimal readability.
- Take advantage of the most dependable drug information available with thoroughly updated, one-of-a-kind Pediatric Formulary providing the standard of pediatric care from the leading pediatric hospital in the world.
- Trust thoroughly updated content that includes parameters for pediatric and neonatal septic shock; guidelines for acute management of severe traumatic brain injury; a convenient table detailing common genetic tests; a significantly extended collection of radiologic images; expanded mental health coverage; plus much more.
- Access information easily and quickly with reformatted sections designed make the book easier to use via mobile device.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| IFC | IFC | ||
| Pediatric Parameters, Equipment, and Resuscitation Medications | i | ||
| The Harriet Lane Handbook: A Manual for Pediatric House Officers | v | ||
| Copyright | vi | ||
| Dedication | vii | ||
| Preface | ix | ||
| Contents | xiii | ||
| PART 1 - PEDIATRIC ACUTE CARE | 1 | ||
| Chapter 1 - Emergency Management | 3 | ||
| I. INITIAL ASSESSMENT: C-A-B | 3 | ||
| II. AIRWAY3-6 | 3 | ||
| III. BREATHING3,4,13,14 | 7 | ||
| IV. CIRCULATION3-5,13 | 8 | ||
| V. ALLERGIC EMERGENCIES (ANAPHYLAXIS)16,17 | 9 | ||
| VI. RESPIRATORY EMERGENCIES18 | 10 | ||
| VII. NEUROLOGIC EMERGENCIES | 13 | ||
| REFERENCES | 17 | ||
| Chapter 2 - Poisonings | 19 | ||
| I. WEBSITES | 19 | ||
| II. INITIAL EVALUATION | 19 | ||
| III. TOXIDROMES (Table 2-2) | 20 | ||
| IV. INGESTION AND ANTIDOTES (TABLE 2-3) | 21 | ||
| V. ACETAMINOPHEN OVERDOSE4,17,18,19,20 | 23 | ||
| VI. LEAD POISONINGS21-23 | 23 | ||
| CHELATION THERAPY | 24 | ||
| REFERENCES | 25 | ||
| Chapter 3 - Procedures | 27 | ||
| I. GENERAL GUIDELINES | 27 | ||
| II. BLOOD SAMPLING | 27 | ||
| III. VASCULAR ACCESS | 31 | ||
| IV. BODY FLUID SAMPLING | 42 | ||
| V. IMMUNIZATION AND MEDICATION ADMINISTRATION4 | 53 | ||
| VI. BASIC LACERATION REPAIR3 | 54 | ||
| VII. MUSCULOSKELETAL PROCEDURES | 57 | ||
| REFERENCES | 60 | ||
| Chapter 4 - Trauma, Burns, and Common Critical Care Emergencies | 61 | ||
| I. TRAUMA: OVERVIEW1 | 61 | ||
| II. SPECIFIC TRAUMATIC INJURIES | 61 | ||
| III. COMMON CRITICAL CARE EMERGENCIES | 68 | ||
| IV. ANIMAL BITES3,18 | 76 | ||
| V. BURNS1,3,19 | 78 | ||
| VI. CHILD ABUSE | 83 | ||
| REFERENCES | 86 | ||
| PART II - DIAGNOSTIC AND THERAPEUTIC INFORMATION | 89 | ||
| Chapter 5 - Adolescent Medicine | 91 | ||
| I. WEBSITES | 91 | ||
| II. INTRODUCTION TO ADOLESCENT HEALTH | 91 | ||
| III. ADOLESCENT HEALTH MAINTENANCE | 94 | ||
| IV. PREPARTICIPATION PHYSICAL EVALUATION (PPE)18,19 | 97 | ||
| V. SEXUAL HEALTH9,20-25 | 98 | ||
| VI. MENTAL HEALTH | 104 | ||
| VII. TRANSITIONING ADOLESCENTS INTO ADULT CARE | 108 | ||
| REFERENCES | 109 | ||
| Chapter 6 - Analgesia and Procedural Sedation | 111 | ||
| I. WEB RESOURCES | 111 | ||
| II. PAIN ASSESSMENT | 111 | ||
| III. ANALGESICS1,4 | 111 | ||
| IV. PATIENT-CONTROLLED ANALGESIA | 116 | ||
| V. OPIOID TAPERING4 | 117 | ||
| VI. PROCEDURAL SEDATION1,4-7,14 | 118 | ||
| REFERENCES | 126 | ||
| Chapter 7 - Cardiology | 127 | ||
| I. WEBSITES | 127 | ||
| II. THE CARDIAC CYCLE (FIG. 7-1) | 127 | ||
| III. PHYSICAL EXAMINATION | 128 | ||
| IV. ELECTROCARDIOGRAPHY | 140 | ||
| V. IMAGING | 154 | ||
| VI. CONGENITAL HEART DISEASE | 155 | ||
| VII. ACQUIRED HEART DISEASE | 161 | ||
| VIII. EXERCISE RECOMMENDATIONS FOR CONGENITAL HEART DISEASE | 168 | ||
| IX. LIPID MONITORING RECOMMENDATIONS | 168 | ||
| X. CARDIOVASCULAR SCREENING | 170 | ||
| REFERENCES | 170 | ||
| Chapter 8 - Dermatology | 172 | ||
| I. WEBSITE | 172 | ||
| II. EVALUATION AND CLINICAL DESCRIPTIONS OF SKIN FINDINGS | 172 | ||
| III. SKIN LUMPS: DIAGNOSIS AND TREATMENT (FIGS. 8-2 TO 8-13) | 172 | ||
| IV. PAPULOSQUAMOUS LESIONS: DIAGNOSIS AND TREATMENT (FIGS. 8-14 TO 8-29) | 180 | ||
| V. HAIR LOSS: DIAGNOSIS AND TREATMENT (FIGS. 8-30 TO 8-34) | 185 | ||
| VI. ACNE VULGARIS | 186 | ||
| VII. COMMON NEONATAL DERMATOLOGIC CONDITIONS (FIGS. 8-35 TO 8-44) | 190 | ||
| VIII. BULLOUS LESIONS: DIAGNOSIS AND TREATMENT (FIGS. 8-45 TO 8-47) | 192 | ||
| REFERENCES | 194 | ||
| Chapter 9 - Development, Behavior, and Mental Health | 195 | ||
| I. WEBSITES | 195 | ||
| II. INTRODUCTION | 195 | ||
| III. DEFINITIONS1 | 195 | ||
| IV. GUIDELINES FOR NORMAL DEVELOPMENT AND BEHAVIOR | 196 | ||
| V. DEVELOPMENTAL SCREENING AND EVALUATION | 200 | ||
| VI. MEDICAL EVALUATION OF DEVELOPMENTAL DISORDERS | 202 | ||
| VII. DISORDERS OF DEVELOPMENT | 205 | ||
| VIII. DISORDERS OF MENTAL HEALTH | 208 | ||
| IX. REFERRAL AND INTERVENTION | 212 | ||
| REFERENCES | 212 | ||
| Chapter 10 - Endocrinology | 214 | ||
| I. WEBSITES | 214 | ||
| II. DIABETES | 214 | ||
| III. THYROID FUNCTION11-13 | 219 | ||
| IV. PARATHYROID GLAND FUNCTION AND VITAMIN D | 224 | ||
| V. ADRENAL FUNCTION21-23 | 226 | ||
| VI. POSTERIOR PITUITARY GLAND—VASOPRESSIN29 | 231 | ||
| VII. GROWTH AND SEXUAL DEVELOPMENT29-38 | 233 | ||
| VIII. NEONATAL HYPOGLYCEMIA EVALUATION40 | 242 | ||
| IX. ADDITIONAL NORMAL VALUES | 243 | ||
| REFERENCES | 243 | ||
| Chapter 11 - Fluids and Electrolytes | 246 | ||
| I. OVERALL GUIDANCE IN FLUID AND ELECTROLYTE MANAGEMENT | 246 | ||
| II. MAINTENANCE REQUIREMENTS | 246 | ||
| III. DEFICIT REPLETION8 | 249 | ||
| IV. ONGOING LOSSES | 256 | ||
| V. SERUM ELECTROLYTE DISTURBANCES | 256 | ||
| VI. ACID-BASE/OSMOLAR GAP DISTURBANCES | 264 | ||
| REFERENCES | 266 | ||
| Chapter 12 - Gastroenterology | 268 | ||
| I. WEBSITES | 268 | ||
| II. GASTROINTESTINAL EMERGENCIES | 268 | ||
| III. CONDITIONS OF THE GI TRACT (ESOPHAGUS/STOMACH/BOWEL) | 270 | ||
| IV. CONDITIONS OF THE LIVER | 276 | ||
| V. PANCREATITIS19,20 | 278 | ||
| REFERENCES | 282 | ||
| Chapter 13 - Genetics: Metabolism and Dysmorphology | 284 | ||
| I. WEBSITES/DATABASES | 284 | ||
| II. METABOLISM | 284 | ||
| III. DYSMORPHOLOGY1,2,13-15 | 295 | ||
| REFERENCES | 303 | ||
| Chapter 14 - Hematology | 305 | ||
| I. ANEMIA | 305 | ||
| II. HEMOGLOBINOPATHIES | 309 | ||
| III. NEUTROPENIA | 313 | ||
| IV. THROMBOCYTOPENIA | 313 | ||
| V. COAGULATION (FIG. 14-2) | 316 | ||
| VI. BLOOD COMPONENT REPLACEMENT | 325 | ||
| VII. INTERPRETING BLOOD SMEARS | 332 | ||
| REFERENCES | 333 | ||
| Chapter 15 - Immunology and Allergy | 334 | ||
| I. ALLERGIC RHINITIS1-4 | 334 | ||
| II. FOOD ALLERGY5-9 | 336 | ||
| III. DRUG ALLERGY10-11 | 339 | ||
| IV. EVALUATION OF SUSPECTED IMMUNODEFICIENCY (TABLES 15-2 AND 15-3)12-19 | 341 | ||
| V. IMMUNOGLOBULIN THERAPY20-22 | 341 | ||
| VI. IMMUNOLOGIC REFERENCE VALUES | 345 | ||
| VII. COMPLEMENT PATHWAY (FIG. 15-3) | 348 | ||
| REFERENCES | 348 | ||
| Chapter 16 - Immunoprophylaxis | 351 | ||
| I. WEBSITES | 351 | ||
| II. IMMUNIZATION SCHEDULES | 351 | ||
| III. IMMUNIZATION GUIDELINES | 351 | ||
| IV. IMMUNOPROPHYLAXIS GUIDELINES FOR SPECIAL HOSTS | 361 | ||
| V. IMMUNOPROPHYLAXIS GUIDELINES FOR SPECIFIC DISEASES | 363 | ||
| REFERENCES | 378 | ||
| Chapter 17 - Microbiology and Infectious Disease | 380 | ||
| I. MICROBIOLOGY | 380 | ||
| II. INFECTIOUS DISEASE | 380 | ||
| REFERENCES | 413 | ||
| Chapter 18 - Neonatology | 415 | ||
| I. WEBSITES | 415 | ||
| III. NEWBORN RESUSCITATION | 415 | ||
| IV. NEWBORN ASSESSMENT | 415 | ||
| II. FETAL ASSESSMENT | 415.e1 | ||
| V. FLUIDS, ELECTROLYTES, AND NUTRITION | 421 | ||
| VI. CYANOSIS IN THE NEWBORN | 423 | ||
| VII. RESPIRATORY DISEASES | 423 | ||
| VIII. APNEA AND BRADYCARDIA | 426 | ||
| IX. CARDIAC DISEASES | 427 | ||
| X. HEMATOLOGIC DISEASES | 428 | ||
| XI. GASTROINTESTINAL DISEASES | 431 | ||
| XII. NEUROLOGIC DISEASES | 431 | ||
| XIII. RETINOPATHY OF PREMATURITY (ROP)11 | 433 | ||
| XIV. CONGENITAL INFECTIONS | 435 | ||
| XV. COMMONLY USED MEDICATIONS IN THE NEONATAL INTENSIVE CARE UNIT (TABLE 18-11) | 435 | ||
| REFERENCES | 437 | ||
| Chapter 19 - Nephrology | 438 | ||
| I. WEBSITES | 438 | ||
| II. URINALYSIS, URINE DIPSTICK, AND MICROSCOPY1 | 438 | ||
| III. EVALUATION AND MANAGEMENT OF URINARY TRACT INFECTIONS3 | 440 | ||
| IV. KIDNEY FUNCTION TESTS | 445 | ||
| V. ACUTE KIDNEY INJURY11,12 | 448 | ||
| VI. HEMATURIA AND ASSOCIATED DISORDERS13,14 | 450 | ||
| VII. PROTEINURIA AND ASSOCIATED DISORDERS14,15 | 454 | ||
| VIII. TUBULAR DISORDERS | 456 | ||
| IX. CHRONIC KIDNEY DISEASE19 | 458 | ||
| X. CHRONIC HYPERTENSION20-22 | 460 | ||
| XI. NEPHROLITHIASIS23,24 | 462 | ||
| REFERENCES | 465 | ||
| Chapter 20 - Neurology | 467 | ||
| I. WEBSITES | 467 | ||
| II. NEUROLOGIC EXAMINATION | 467 | ||
| III. HEADACHES1-3 | 470 | ||
| IV. PAROXYSMAL EVENTS | 474 | ||
| V. HYDROCEPHALUS19 | 480 | ||
| VI. ATAXIA20,21 | 480 | ||
| VII. STROKE22-25 | 481 | ||
| REFERENCES | 483 | ||
| Chapter 21 - Nutrition and Growth | 485 | ||
| I. WEBSITES | 485 | ||
| II. ASSESSMENT OF NUTRITIONAL STATUS | 485 | ||
| III. ESTIMATING ENERGY NEEDS | 497 | ||
| IV. DIETARY REFERENCE INTAKES FOR INDIVIDUALS7 | 500 | ||
| V. ENTERAL NUTRITION | 509 | ||
| VI. PARENTERAL NUTRITION12 | 520 | ||
| REFERENCES | 522 | ||
| Chapter 22 - Oncology | 523 | ||
| I. WEBSITES | 523 | ||
| II. PRESENTING SIGNS AND SYMPTOMS OF PEDIATRIC MALIGNANCIES (TABLE 22-1) | 523 | ||
| III. EVALUATION OF LYMPHADENOPATHY2,3 | 524 | ||
| IV. COMMONLY USED CHEMOTHERAPEUTIC DRUGS AND ASSOCIATED ACUTE TOXICITIES (TABLE 22-2) | 525 | ||
| V. ONCOLOGIC EMERGENCIES1,4,5 | 529 | ||
| VI. HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)1,6 | 532 | ||
| VII. COMMON COMPLICATIONS OF BONE MARROW TRANSPLANTATION1,6 | 534 | ||
| VIII. HEMATOLOGIC CARE AND COMPLICATIONS1 | 536 | ||
| IX. NAUSEA TREATMENT IN CANCER PATIENTS1 | 537 | ||
| X. ANTIMICROBIAL PROPHYLAXIS IN ONCOLOGY PATIENTS (TABLE 22-3) | 538 | ||
| XI. BEYOND CHILDHOOD CANCER: TREATING A CANCER SURVIVOR1,7,8 | 538 | ||
| REFERENCES | 539 | ||
| Chapter 23 - Palliative Care | 540 | ||
| I. PALLIATIVE CARE | 540 | ||
| II. COMMUNICATION AND DECISION MAKING | 541 | ||
| III. LEGACY AND MEMORY MAKING | 543 | ||
| IV. DECISIONS TO LIMIT INTERVENTIONS | 543 | ||
| V. BODY, MIND, AND SPIRIT CHANGES AS DEATH APPROACHES9 | 544 | ||
| VI. LAST HOURS: MEDICATION AND MANAGEMENT10 (TABLE 23-2) | 545 | ||
| VII. DEATH PRONOUNCEMENT11 | 545 | ||
| VIII. AFTER DEATH—BEREAVEMENT11 | 547 | ||
| REFERENCES | 547 | ||
| Chapter 24 - Pulmonology | 549 | ||
| I. WEBSITES | 549 | ||
| II. RESPIRATORY PHYSICAL EXAMINATION | 549 | ||
| III. EVALUATION OF PULMONARY GAS EXCHANGE | 549 | ||
| IV. PULMONARY FUNCTION TESTS | 551 | ||
| V. APPARENT LIFE-THREATENING EVENT (ALTE)12,13 | 556 | ||
| VI. ASTHMA15 | 558 | ||
| VII. BRONCHIOLITIS16 | 565 | ||
| VIII. BRONCHOPULMONARY DYSPLASIA(BPD)17-19 | 566 | ||
| IX. CYSTIC FIBROSIS (CF)20-22 | 566 | ||
| X. OBSTRUCTIVE SLEEP APNEA SYNDROME (OSAS)23-26 | 568 | ||
| XI. SUDDEN INFANT DEATH SYNDROME27 | 570 | ||
| REFERENCES | 570 | ||
| Chapter 25 - Radiology | 572 | ||
| I. GENERAL PEDIATRIC PRINCIPLES | 572 | ||
| II. HEAD 2 | 572 | ||
| III. EYES 4 | 573 | ||
| IV. SPINE | 573 | ||
| V. AIRWAY 3 | 576 | ||
| VI. CHEST3,4 | 577 | ||
| VII. HEART AND VESSELS 3 | 583 | ||
| VIII. ABDOMEN3-5 | 584 | ||
| IX. GENITOURINARY TRACT 3 | 589 | ||
| X. EXTREMITIES 3,5 | 589 | ||
| REFERENCES | 601 | ||
| Chapter 26 - Rheumatology | 602 | ||
| I. WEBSITE | 602 | ||
| II. LABORATORY STUDIES | 602 | ||
| III. ARTHRITIDES | 606 | ||
| IV. SYSTEMIC LUPUS ERYTHEMATOSUS | 609 | ||
| V. VASCULITIS | 612 | ||
| VI. GRANULOMATOUS DISEASE | 615 | ||
| VII. OTHER RHEUMATIC DISEASES | 616.e1 | ||
| REFERENCES | 617 | ||
| PART III - REFERENCE | 619 | ||
| Chapter 27 - Blood Chemistries and Body Fluids | 621 | ||
| I. REFERENCE VALUES (TABLE 27-1) | 621 | ||
| II. EVALUATION OF BODY FLUIDS | 630 | ||
| III. CONVERSION FORMULAS | 633 | ||
| REFERENCES | 633 | ||
| Chapter 28 - Biostatistics and Evidence-Based Medicine | 634 | ||
| I. WEBSITES | 634 | ||
| II. EVIDENCE-BASED MEDICINE | 634 | ||
| III. BIOSTATISTICS FOR MEDICAL LITERATURE | 635 | ||
| REFERENCES | 641 | ||
| PART IV - FORMULARY | 643 | ||
| Chapter 29 - Drug Dosages | 645 | ||
| I. NOTE TO READER | 645 | ||
| II. SAMPLE ENTRY | 647 | ||
| III. EXPLANATION OF BREAST-FEEDING CATEGORIES | 648 | ||
| IV. EXPLANATION OF PREGNANCY CATEGORIES | 648 | ||
| V. DRUG INDEX | 648 | ||
| Bibliography | 985 | ||
| Chapter 30 - Formulary Adjunct | 987 | ||
| I. WEBSITES | 987 | ||
| II. SYSTEMIC CORTICOSTEROIDS | 987 | ||
| III. INHALED CORTICOSTEROIDS FOR AIRWAY INFLAMMATION | 987 | ||
| IV. TOPICAL CORTICOSTEROIDS | 987 | ||
| V. COMMON INSULIN FORMULATIONS | 987 | ||
| VI. PANCREATIC ENZYME SUPPLEMENTS | 987 | ||
| VII. COMMON INDUCERS AND INHIBITORS OF THE CYTOCHROME P450 SYSTEM | 987 | ||
| VIII. OPHTHALMIC DRUGS | 987 | ||
| IX. PSYCHIATRIC DRUG FORMULARY | 993 | ||
| X. CHEMOTHERAPEUTIC AGENTS | 993 | ||
| XI. OXIDIZING AGENTS AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) DEFICIENCY | 993 | ||
| REFERENCE | 993 | ||
| Chapter 31 - Drugs in Renal Failure | 994 | ||
| I. DOSE ADJUSTMENT METHODS | 994 | ||
| II. Antimicrobials Requiring Adjustment in Renal Failure (Table 31-1) | 994 | ||
| III. NON-ANTIMICROBIALS REQUIRING ADJUSTMENT IN RENAL FAILURE (TABLE 31-2) | 994 | ||
| REFERENCES | 1017 | ||
| Index | 1019 | ||
| Pediatric Advanced Life Support (PALS) Algorithms Part 1 | 1134 | ||
| Color Plates | CP1 | ||
| Pediatric Advanced Life Support (PALS) Algorithms Part 2 | IBC |